"Liver Specialists of Texas provides a wide range of specialized care to patients with digestive and liver disorders. We are located at 6560 Fannin Street, Suite 2050. Our main office, located in Scurlock Towers, is a 5000 square foot facility, with a spacious waiting room, 7 examinations rooms, clinical research facilities, ultrasound lab, fibroscan, and physician consultation offices. Our warm receptive staff is available for all of your needs. At this location, all of the outpatient consultations take place. Detailed medical histories are obtained along with a thorough physical examination."

During the past decade, Liver Associates of Texas conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 12 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Liver Associates of Texas" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Conatus Pharmaceuticals Inc." with 3 trials sponsored, "Intercept Pharmaceuticals" with 3 trials sponsored, "Madrigal Pharmaceuticals, Inc." with 3 trials sponsored and "Genfit" with 3 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 18 trials in total.

According to Clinical.Site data, the most researched conditions in "Liver Associates of Texas" are "Hepatitis C" (4 trials), "Non-Alcoholic Fatty Liver Disease" (3 trials), "Nonalcoholic Steatohepatitis" (3 trials), "Hepatitis C, Chronic" (2 trials) and "NASH - Nonalcoholic Steatohepatitis" (2 trials). Many other conditions were trialed in "Liver Associates of Texas" in a lesser frequency.

Most popular intervention types in "Liver Associates of Texas" are "Drug" (25 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Emricasan (5 mg)" (2 trials), "Obeticholic Acid" (2 trials), "Resmetirom" (2 trials) and "Ribavirin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Liver Associates of Texas" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Liver Associates of Texas". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Liver Associates of Texas, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Liver Associates of Texas, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".